S. Lynch

发表

Journal of the International Aids Society Open Access Antiretroviral Treatment Outcomes from a Nurse-driven, Community-supported Hiv/aids Treatment Programme in Rural Lesotho: Observational Cohort Assessment at Two Years

N. Ford, H. Bygrave, E. Goemaere, 2022 .

International nurse migration and HIV/AIDS.

N. Ford, S. Lynch, Pheello Lethola, 2008, JAMA.

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis

J. Furin, Michael Rich, G. Brigden, 2016, Emerging infectious diseases.

Why it’s time to say goodbye to stavudine ... everywhere

S. Collins, E. Goemaere, P. Clayden, 2012 .

Countries are out of step with international recommendations for tuberculosis testing, treatment, and care: Findings from a 29-country survey of policy adoption and implementation

C. Perrin, L. Diţiu, S. Sahu, 2019, bioRxiv.

Getting HIV Treatment to the Most People

N. Ford, H. Bygrave, C. Ferreyra, 2012, Science.

Preferred antiretroviral drugs for the next decade of scale up

N. Ford, C. Katlama, P. Cahn, 2012, Journal of the International AIDS Society.

Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis.

V. Cox, J. Furin, M. Rich, 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The case for Option B and Optional B+: Ensuring that South Africa’s commitment to eliminating mother-to-child transmission of HIV becomes a reality

N. Ford, H. Bygrave, E. Goemaere, 2012 .

Urine LAM diagnostics can close the deadly testing gap for TB.

S. Deborggraeve, L. McKenna, S. Lynch, 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The 1/4/6x24 campaign to cure tuberculosis quickly

M. Pai, C. Mitnick, L. McKenna, 2023, Nature Medicine.

N. Ford, H. Bygrave, E. Goemaere, 2022 .